KOD News and Press, Kodiak Sciences Inc From 12/17/25

2025-12-17 10:16:08 ET Kodiak Sciences Inc. (NASDAQ: KOD) is one of today’s top gainers. The company’s shares have moved 15.17% on the day to $27.79. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics...

2025-12-17 02:45:55 ET Kodiak Sciences ( KOD ) has priced an expanded public offering of approximately 6.96 million shares at $23.00 each. The company expects to raise roughly $160 million in gross proceeds.... Read the full article on Seeking Alpha For f...

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock PR Newswire PALO ALTO, Calif. , Dec. 16, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commerc...

2025-12-16 09:19:08 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers’ 13F stock portfolio on a quarterly basis. It is based on Baker Brothers’ regulatory 13F Form filed on 11/14/2025. The 13F portfolio value in...

2025-12-15 16:06:49 ET More on Kodiak Sciences Kodiak Sciences: Retinal Specialist Highlights Its Top Three Programs Kodiak spikes as J.P. Morgan upgrades on eye disease drug, KSI-101 Kodiak gains as Barclays upgrades on Roche data for eye disease drug Seekin...

Kodiak Sciences Announces Proposed Public Offering of Common Stock PR Newswire PALO ALTO, Calif. , Dec. 15, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing t...

2025-12-09 09:56:32 ET Shares of Kodiak Sciences Inc. (NASDAQ: KOD) traded at a new 52-week high today and are currently trading at $25.1. So far today, approximately 55,353 shares have been exchanged, as compared to an average 30-day volume of 735.76k shares. Kodiak Sciences Inc., ...

2025-12-09 04:20:00 ET The vast majority of asset management companies today use model portfolios. Model portfolios, which surged to a record $7.7 trillion in assets in early 2025, offer a way for advisors to outsource portfolio construction and rebalancing. The proliferation of model p...

2025-12-04 07:13:27 ET ... Read the full article on Seeking Alpha For further details see: Kodiak Sciences: Retinal Specialist Highlights Its Top Three Programs

2025-11-13 16:50:28 ET More on Kodiak Sciences Kodiak Sciences: Odds May Be Narrowing For Longer Lasting Eye Disease Med Approval Kodiak spikes as J.P. Morgan upgrades on eye disease drug, KSI-101 Kodiak gains as Barclays upgrades on Roche data for eye disease drug ...